DNB ASSET MANAGEMENT AS – Regeneron Pharmaceuticals, Inc. Transaction History
DNB ASSET MANAGEMENT AS portfolio value:
$14.28M
portfolio value
DNB ASSET MANAGEMENT AS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -32.83% | -10.14K shares | -3.96M | $688.87 | 20.74K |
Q2 2022 | share | Decrease | -5.12% | -1.66K shares | -4.47M | $591.13 | 30.88K |
Q1 2022 | share | Decrease | -3.76% | -1.27K shares | 1.37M | $698.42 | 32.54K |
Q4 2021 | share | Decrease | -15.97% | -6.42K shares | -2.99M | $642.51 | 33.81K |
Q3 2021 | share | Decrease | -14.89% | -7.04K shares | -2.05M | $605.18 | 40.24K |
Q2 2021 | share | Increase | +12.34% | 5.19K shares | 6.49M | $558.54 | 47.29K |
Q1 2021 | share | Increase | +13.45% | 4.99K shares | 1.99M | $473.14 | 42.09K |
Q4 2020 | share | Increase | +2.19% | 795 shares | -2.39M | $483.11 | 37.10K |
Q3 2020 | share | Decrease | -53.21% | -41.28K shares | -28.06M | $559.78 | 36.30K |
Q2 2020 | share | Increase | +16.95% | 11.24K shares | 15.99M | $623.65 | 77.59K |
Q1 2020 | share | Increase | +7.17% | 4.43K shares | 9.15M | $488.29 | 66.34K |
Q4 2019 | share | Increase | +22.42% | 11.33K shares | 9.21M | $375.48 | 61.90K |
Q3 2019 | share | Increase | +58.93% | 18.75K shares | 4.06M | $277.4 | 50.57K |
Q2 2019 | share | Decrease | -35.59% | -17.58K shares | -10.32M | $313 | 31.81K |
Q1 2019 | share | Decrease | -7.66% | -4.09K shares | 302.71K | $410.62 | 49.39K |
Q4 2018 | share | Increase | +136.40% | 30.86K shares | 10.83M | $373.5 | 53.49K |
Q3 2018 | share | Increase | 0.00% | 22.63K shares | 9.14M | $404.04 | 22.63K |
Q2 2018 | share | Decrease | -100.00% | -26.4K shares | -9.09M | $344.99 | 0 |
Q1 2018 | share | Increase | +8.64% | 2.1K shares | -44.72K | $344.36 | 26.4K |
Q4 2017 | share | Increase | 0.00% | 24.3K shares | 9.13M | $375.96 | 24.3K |